Skip to content

Clinical effectiveness of repetitve transcranial magnetic stimulation (rTMS) as an adjunctive therapy in depression - a catchment area-based randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN70121208
Enrollment
54
Registered
2007-03-05
Start date
2002-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder Mental and Behavioural Disorders Depression

Interventions

Real or sham repetitve transcranial magnetic stimulation (rTMS)

Sponsors

South London and Maudsley NHS Trust (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Over 18 years old, right-handed and have a diagnosis of major depressive disorder (DSM-IV)

Exclusion criteria

Exclusion criteria: 1. History of seizures 2. Head injury with loss of consciousness 3. Brain surgery 4. Presence of metallic implants 5. Evidence of dementia or other Axis 1 diagnosis 6. Substance misuse within the previous six months 7. Previous treatment with rTMS 8. Inability to provide informed consent

Design outcomes

Primary

MeasureTime frame
Hamilton Rating Scale for Depression (HDRS)

Secondary

MeasureTime frame
Clinical: 1. Beck Depression Inventory-II (BDI-II) 2. Visual Analogue Mood Scales (VAMS) 3. Brief Psychiatric Rating Scale (BPRS) Subjective side-effects: 1. Modified Columbia ECT Subjective Side Effects Schedule (CSSES) Cognition: 1. CAMCOG, digit-span test 2. Digit symbols modalities test 3. Grooved pegboard test Quality of life: SF-36 questionnaire Economic: Client Service Receipt Inventory (CSRI)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026